A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors

NCT00276913 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Synta Pharmaceuticals Corp.